Clinical Pharmacokinetics: cram pack

Formula sheets, the key method steps for every topic and 8 practice problems, with full solutions at the back.

New problemsBack to the course

In the print window, choose “Save as PDF” to keep a copy on your device.

1Formulas and methods

Clinical pharmacokinetics

Rate constant and half-life
k = ln 2/t½ = 0.693/t½
First-order decay
C = C₀·e−kt = C₀·(1/2)t/t½
Two levels
k = ln(C₁/C₂)/Δt
Volume and clearance
Vd = dose/C₀, CL = k·Vd
Loading dose
LD = Vd·C/(S·F)
Maintenance rate
R = CL·Css/(S·F)
Average steady state
Css,avg = S·F·D/(CL·τ)
Steady state
1 − (1/2)ⁿ after n half-lives; ≈ 97% after 5
Infusion
C = (R/CL)(1 − e−kt)
Interval and dose from peak and trough
τ = ln(Cpeak/Ctrough)/k, D = Vd·(Cpeak − Ctrough)
Cockcroft–Gault
CrCl = (140 − age) × kg/(72 × SCr mg/dL), × 0.85 for women
Renal adjustment
dose × CrCl/normal; Dettli Q = 1 − fe·(1 − CrCl/normal)

Method

  1. Convert the half-life to a rate constant: k = 0.693/t½.
  2. Turn per-kg values into totals: Vd (L) = L/kg × weight, CL (L/h) = L/kg/h × weight.
  3. Pick the relation: C = C₀·e−kt, LD = Vd·C/(S·F), maintenance rate = CL·Css/(S·F), τ = ln(Cpeak/Ctrough)/k.
  4. For kidney function, estimate CrCl with Cockcroft–Gault first, then scale the dose or the interval.
  5. Check the result: levels fall by half every half-life, and steady state takes about five half-lives.

Pharmacy calculations

Percentage strength
% w/v = g per 100 mL
Amount in a solution
g = % × mL / 100
Ratio strength
1:X = 1 g in X mL; % = 100 / X
Reconstitution
final volume = diluent + powder volume
Concentration
mg/mL = drug in vial / final volume
Alligation
parts of H = T − L, parts of L = H − T
Water or base
0%

Pediatric & critical-care dosing

Daily dose
mg/day = mg/kg/day × weight (kg)
Doses per day
number = 24 h / dosing interval (h)
Pounds to kilograms
kg = lb / 2.2
Infusion concentration
units/mL = units in bag / bag volume
Pump rate
mL/h = dose per hour / concentration
Titrated drip
mL/h = mcg/kg/min × kg × 60 / (mcg/mL)
Dose from pump rate
mcg/kg/min = mL/h × (mcg/mL) / (60 × kg)
Units
1 mg = 1000 mcg

2Practice problems

1.Clinical pharmacokineticsMedium
110100t (h)C (mg/L)1 h25 mg/L13 h6.3 mg/L

Practice exercise (made-up values, not clinical guidance). After an IV dose of vancomycin, the level is 25 mg/L at 1 h and 6.3 mg/L at 13 h. Assume first-order elimination. Find the half-life t½.

C1 = 25 mg/L (1 h)C2 = 6.3 mg/L (13 h)
t½ = h
2.Clinical pharmacokineticsHard
t (h)C (mg/L)Css​12 hC = ?

Practice exercise (made-up values, not clinical guidance). A vancomycin infusion runs at 60 mg/h with no loading dose. The patient's clearance is 3 L/h and the half-life is 10 h. What is the level C after 12 h?

R = 60 mg/hCL = 3 L/ht½ = 10 ht = 12 h
C = mg/L
3.Pharmacy calculationsMedium
00.10.20.30.40.50.60.70.80.911 mL

A solution has a ratio strength of 1:1000. You need 0.29 mg. Draw up the volume in the 1 mL syringe: what volume V is that?

1:10000.29 mg
V = mL
4.Pharmacy calculationsHard
0123455 mL

A vial holds 500 mg of powder. You add 4.6 mL of diluent, and the powder adds 0.4 mL of volume. The prescription is 150 mg. Draw up the dose: what volume V do you give?

500 mg4.6 mL + 0.4 mL150 mg
V = mL
5.Pediatric & critical-care dosingMedium
heparin 1 000 units/mL70 units/kg · 87 kg → V = ? mL

Practice exercise (made-up values, not clinical guidance). A practice protocol calls for a heparin bolus of 70 units/kg for a patient who weighs 87 kg. The vial contains 1 000 units/mL. What volume V do you draw up? Round to one decimal place.

70 units/kg87 kg1 000 units/mL
V = mL
6.Pediatric & critical-care dosingHard
50 mg250 mLnitroglycerin? mL/h71 kg10 mcg/min

Practice exercise (made-up values, not clinical guidance). A patient who weighs 71 kg has an order for nitroglycerin at 10 mcg/min. The bag contains 50 mg in 250 mL. Find the pump rate R in mL/h. Round to one decimal place.

50 mg/250 mL10 mcg/min71 kg
R = mL/h
7.PharmacologyMedium

A person who has never been vaccinated against tetanus has a deep, dirty wound. What is usually given?

  1. ANo treatment unless symptoms appear
  2. BOral antibiotics only
  3. CTetanus vaccine only, after the wound heals
  4. DTetanus vaccine and tetanus immunoglobulin
8.PharmacologyHard

Which antiepileptic drug carries the highest well-known risk of neural tube defects and developmental problems when taken in pregnancy?

  1. ALevetiracetam
  2. BSodium valproate
  3. CLamotrigine
  4. DGabapentin

3Solutions

1.Clinical pharmacokinetics

Answer: t½ = 6.035 h

Clearance and volume: at steady state the dosing rate equals the elimination rate, so the maintenance rate = CL × Css. A loading dose is LD = Vd × C/(S × F), with S the salt factor (fraction of active drug in the salt) and F the bioavailability (1 for IV). From two levels, k = ln(C₁/C₂)/Δt; for an IV bolus Vd = dose/C₀ and CL = k × Vd. The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.

Elimination rate constant

k = ln(25/6.3)/12 = 1.378/12 = 0.1149 h⁻¹

Half-life

t½ = 0.693/0.1149 = 6.035 h

Answer

t½ = 6.035 h
2.Clinical pharmacokinetics

Answer: C = 11.29 mg/L

Designing a regimen: with rapid IV doses the level falls from peak to trough during the interval, so τ = ln(Cpeak/Ctrough)/k and the dose that restores the peak is Vd × (Cpeak − Ctrough). The average steady-state level is Css,avg = S·F·dose/(CL·τ). An infusion rises as C = (R/CL)(1 − e−kt). For a drug cleared by the kidneys, the dose is scaled with the creatinine clearance. The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.

Steady-state level

Css = 60/3 = 20 mg/L

Rate constant

k = 0.693/10 = 0.06931 h⁻¹

Level after the given time

C = 20·(1 − e−0.06931·12) = 11.29 mg/L

Answer

C = 11.29 mg/L
3.Pharmacy calculations

Answer: V = 0.29 mL

Strength to volume: turn the strength into mg per mL first. A w/v percentage is grams per 100 mL, so x% = 10x mg/mL. A ratio strength 1:n is 1 g in n mL. After reconstitution the concentration is the powder's dose over the final volume (diluent + powder volume). Then volume = dose/concentration.

Strength in mg/mL

1000 mg/1000 mL = 1 mg/mL

Volume

V = 0.29/1 = 0.29 mL

Answer

V = 0.29 mL
4.Pharmacy calculations

Answer: V = 1.5 mL

Strength to volume: turn the strength into mg per mL first. A w/v percentage is grams per 100 mL, so x% = 10x mg/mL. A ratio strength 1:n is 1 g in n mL. After reconstitution the concentration is the powder's dose over the final volume (diluent + powder volume). Then volume = dose/concentration.

Final volume and concentration

4.6 + 0.4 = 5 mL
C = 500/5 = 100 mg/mL

Volume

V = 150/100 = 1.5 mL

Answer

V = 1.5 mL
5.Pediatric & critical-care dosing

Answer: V = 6.1 mL

Heparin and insulin infusions: concentration = units in the bag/bag volume (units/mL). Pump rate (mL/h) = units per hour/concentration, and units per hour = mL/h × concentration. For a weight-based order, units/h = units/kg/h × weight first. A bolus volume = units needed/vial strength. The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.

Units needed

70·87 = 6 090 units

Volume

V = 6090/1000 = 6.09 ≈ 6.1 mL

Answer

V = 6.1 mL
6.Pediatric & critical-care dosing

Answer: R = 3 mL/h

Titrated drips: first find the concentration in mcg/mL (mg × 1000/mL). For a weight-based order, mcg/min = mcg/kg/min × weight. Then mL/h = mcg/min × 60/concentration. Working backwards, mcg/kg/min = mL/h × concentration/(60 × weight). The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.

Concentration

50 000/250 = 200 mcg/mL

Dose per hour

The order is per minute for the whole patient, so the weight is not needed.

10·60 = 600 mcg/h

Pump rate

R = 600/200 = 3 mL/h

Answer

R = 3 mL/h
7.Pharmacology

Answer: D · Tetanus vaccine and tetanus immunoglobulin

Why this is the answer

Tetanus immunoglobulin gives immediate passive protection, while the vaccine starts active immunity. Thorough wound cleaning is also essential.

Answer

D · Tetanus vaccine and tetanus immunoglobulin
8.Pharmacology

Answer: B · Sodium valproate

Why this is the answer

Valproate is strongly teratogenic, causing neural tube defects and other malformations, and it affects neurodevelopment. It should be avoided in pregnancy unless no alternative works.

Answer

B · Sodium valproate

ExamProblems · examproblems.com/courses/clinical-pharmacokinetics